Myasthenia gravis: open trials in China

42 open trials have a site in China. Registry data; only the trial team decides who can take part.

NCT07463521
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
Trial Treatment · Phase 3 · UCB Biopharma SRL
Mg0038 31901, Beijing · Mg0038 31912, Beijing · Mg0038 31911, Beijing · Mg0038 31906, Chengdu · Mg0038 31908, Chongqing · Mg0038 31907, Nanchang · Mg0038 31902, Suzhou
Registry updated 2026-11-06
NCT07465289
A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
Trial Treatment · Phase 3 · UCB Biopharma SRL
Mg0039 31901, Beijing · Mg0039 31912, Beijing · Mg0039 31908, Chongqing · Mg0039 31907, Nanchang · Mg0039 31902, Suzhou
Registry updated 2026-11-06
NCT04951622
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Xuanwu Hospital, Capital Medical University, Beijing · Beijing Hospital, Beijing · Beijing Tiantan Hospital,Capital Medical University, Beijing · The First Bethune Hospital of Jilin University, Changchun · Xiangya Hospital Central South University, Changsha · West China Hospital of Sichuan University, Chengdu · Fujian Medical University Union Hospital, Fuzhou · The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou · Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou · Qianfoshan Hospital of Shandong Province, Jinan · Qilu Hospital of Shandong University, Jinan · Huashan Hospital, Fudan University, Shanghai · Tianjin Medical University General Hospital, Tianjin · The Second Affiliated Hospital of Air Force Medical University - Tangdu Hospital, Xi'an
Registry updated 2026-11-05
NCT07917923
A Clinical Study to Evaluate the Safety and Efficacy of GT802 Injection in the Treatment of Refractory Generalized Myasthenia Gravis
Trial Treatment · Early phase 1 · Daishi Tian
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Registry updated 2026-11-05
NCT07622342
A Phase II Study of SHR-2173 Injection in Patients With Myasthenia Gravis
Trial Treatment · Phase 2 · Guangdong Hengrui Pharmaceutical Co., Ltd
Xiangya Hospital of Central South University, Changsha · Huashan Hospital, Fudan University, Shanghai
Registry updated 2026-10-22
NCT06463587
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
Trial Treatment · Phase 3 · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
The First Affiliated Hospital of Bengbu Medical College, Anhui Sheng · Xuanwu Hospital, Capital Medical University, Beijing · Peking Union Medical College Hospital, Beijing · China-Japan Union Hospital of Jilin University - 300173736, Changchun · The First Hospital of Jilin University - The First Hospital of Jilin University, Changchun · Xiangya Hospital Central South University, Changsha · West China Hospital，Sichuan University, Chengdu · The First Affiliated Hospital of Guangzhou University of Chinese Medicine - 300164595, Guangzhou · Huashan Hospital Fudan University-Neurology, Shanghai · Shengjing Hospital Of China Medical University, Shenyang · Shijiazhuang People's Hospital, Shijiazhuang · Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan · Xi'an International Medical Center, Xi'an · Henan Provincial People's Hospital, Zhengzhou · Affiliated Hospital of Zunyi Medical University, Zunyi
Registry updated 2026-10-21
NCT07596784
Efficacy and Safety of Ravulizumab in Chinese Adults Participants With Generalized Myasthenia Gravis (gMG)
Trial Treatment · Phase 3 · Alexion Pharmaceuticals, Inc.
Beijing · Changchun · Fuzhou · Jinan · Shanghai · Shijiazhuang · Taiyuan · Tianjin · Wuhan · Zhengzhou
Registry updated 2026-10-21
NCT07022197
Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases
Trial Treatment · Phase 1/2 · Tianjin Medical University General Hospital
Tianjin Medical University General Hospital, Tianjin
Registry updated 2026-10-16
NCT07818291
An Open-label, Dose-escalation Phase Ib Study of EA5 Injection in Adults With Anti-AChR Antibody-Positive Generalized Myasthenia Gravis
Trial Treatment · Phase 1 · Shanghai Lanyi Therapeutics Co., Ltd.
Beijing Hospital, Beijing · Huashan Hospital, Fudan University, Shanghai
Registry updated 2026-09-14
NCT07215650
Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG)
Trial Treatment · Phase 1 · Candid Therapeutics
The First Hospital of Jilin University, Changchun · Sichuan Provincial People's Hospital, Chengdu · Union Hospital Affiliated to Fujian Medical University, Fuzhou · The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou · The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine, Guangzhou · The Affiliated Hospital of Guizhou Medical University, Guiyang · Huashan Hospital Affiliated to Fudan University, Shanghai · The First Hospital of Shanxi Medical University, Taiyuan · Tianjin Medical University General Hospital, Tianjin · The First Affiliated Hospital of Zhengzhou University, Zhengzhou
Registry updated 2026-09-02
NCT06447597
A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis.
Trial Treatment · Phase 2/3 · Shanghai Jiaolian Drug Research and Development Co., Ltd
Peking University First Hospital, Beijing · The First Bethune Hospital of Jilin University, Changchun · Xiangya Hospital Central South University, Changsha · Sichuan Provincial People's Hospital, Chengdu · Nanfang Hospital, Southern Medical University, Guangzhou · The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou · Shandong University Cheeloo College of Medicine, Jinan · Shandong Provincial Qianfoshan Hospital, Jinan · First People's Hospital of Yunnan Province, Kunming · Jiangxi Provincial People's Hospital, Nanchang · The Second Affiliated Hospital of Nanchang University, Nanchang · Shandong University Cheeloo College of Medicine, Qingdao · Huashan Hospital, Fudan University, Shanghai · Shenzhen Hospital of University of Hong Kong, Shenzhen · Renmin Hospital of Wuhan University, Wuhan · Tongji Medical college of HUST, Wuhan · Tangdu Hospital, Xi'an · Affiliated Hospital of Zunyi Medical College, Zunyi
Registry updated 2026-08-14
NCT06688435
A Study to Evaluate the Safety and Preliminary Efficacy of SYS6020 CAR T-cells in Patients With Refractory Generalized Myasthenia Gravis
Trial Treatment · Phase 1 · CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Qilu Hospital，Shandong University, Jinan
Registry updated 2026-08-12
NCT07556120
Efficacy and Safety of HN2301 in Patients With Generalized Myasthenia Gravis (MG)
Trial Treatment · Phase 1 · Shenzhen MagicRNA Biotechnology Co., Ltd
The First Affiliated Hospital of University of Science and Technology of China, Hefei
Registry updated 2026-08-12
NCT06502015
Biomarkers in Autoimmune Disease of Nervous System
Research · Tongji Hospital
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Registry updated 2026-07-29
NCT07714798
Universal STAR-T Cell Injection in Generalized Myasthenia Gravis
Trial Treatment · Phase 1 · Daishi Tian
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology, Wuhan
Registry updated 2026-07-20
NCT07676266
A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy
Trial Treatment · Phase 1 · The Affiliated Hospital of Qingdao University
The Affiliated Hospital of Qingdao University, Qingdao
Registry updated 2026-06-30
NCT07653984
Cohort Study on Neuroimmune Diseases in the Reproductive Age
Research · Third Affiliated Hospital, Sun Yat-Sen University
The Third Affiliated Hospital,Sun Yat-Sen University, Guangzhou
Registry updated 2026-06-17
NCT07593911
A Study to Evaluate MTM-H-001 Injection in Adult Patients With B-Cell-Related Autoimmune Diseases
Trial Treatment · Beijing GoBroad Hospital
Beijing GoBroad Hospital, Beijing
Registry updated 2026-05-18
NCT07337785
CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases
Trial Treatment · Early phase 1 · Tongji Hospital
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Registry updated 2026-05-12
NCT07526493
Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.
Trial Treatment · Phase 1 · Tongji Hospital
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Registry updated 2026-05-12
NCT07249632
A Study of Telitacicept in Patients With Ocular Myasthenia Gravis (OMG)
Trial Treatment · Phase 3 · RemeGen Co., Ltd.
Beijing Hospital, Beijing
Registry updated 2026-04-09
NCT07413835
Efficacy and Safety of HN2302 in Refractory Myasthenia Gravis(MG)
Trial Treatment · The Affiliated Hospital of Xuzhou Medical University
The affiliated hospital of xuzhou medical university, Xuzhou
Registry updated 2026-03-18
NCT07470151
Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases
Trial Treatment · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Registry updated 2026-03-13
NCT07298928
A Study on the Efficacy and Safety of Telitacicept in the Treatment of Children Ocular Myasthenia Gravis
Trial Treatment · The Children's Hospital of Zhejiang University School of Medicine
The Children's Hospital, Zhejiang University School of Medicine, Hangzhou · Children's Hospital Affiliated to Shandong University, Jinan · Shenzhen children's Hospital of China Medical University, Shenzhen
Registry updated 2026-03-06
NCT04202341
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Research · Alexion Pharmaceuticals, Inc.
Beijing · Changchun · Chengdu · Guangzhou · Jinan · Nanchang · Qingdao · Shijiazhuang
Registry updated 2026-02-18

All Myasthenia gravis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error